AGT and fibrosis: In contrast, cardiac miR-133a was reduced in TAC mouse model and an in vitro fibrosis model using neonatal rat primary ventricular fibroblasts treated with Ang-II (137), again indicating that miRNAs can be differently regulated in diastolic vs. systolic HF.